ِِِAmprobate Oral Solution

Composition

Each 1 ml contains:

  • Amprolium hydrochloride: 250 mg
  • Ethopabate: 16 mg

Pharmacological Properties

Amprobate Oral Solution combines two synergistic anticoccidial agents for enhanced efficacy.
Amprolium hydrochloride, a pyrimidine derivative, disrupts thiamine metabolism in coccidia, effectively inhibiting their development.
Ethopabate complements this action by targeting resistant strains such as Eimeria brunetti and E. maxima, ensuring broad-spectrum control.
This dual mechanism provides superior protection and treatment across a wide range of Eimeria species.

Target Species

Poultry and other animals

Indications for Use

Amprobate Oral Solution is highly effective in both the prevention and treatment of intestinal and caecal coccidiosis in poultry caused by the following Eimeria species:
E. necatrix, E. acervulina, E. maxima, E. mivati, E. brunetti, and E. tenella.
Recommended for use in broilers, pullets, layers, and breeders.

Contraindications

None known.

Undesirable Effects

No undesirable effects have been reported when used as recommended.

Posology and Method of Administration

Poultry:

  • Treatment: 1 ml per 1 liter of drinking water daily for 5–7 days
  • Prevention: 1 ml per 2 liters of drinking water daily for 5–7 days

Other animals:

  • 1 ml per 10 kg body weight daily for 5–7 days

Ensure continuous access to medicated water during the entire treatment period.

Overdose

No adverse effects have been observed at recommended dosages.

Withdrawal Period

Animals and birds must not be slaughtered for human consumption within 24 hours of the last treatment.

Special Safety Precautions for the Person Administering the Product

No specific precautions are required. Basic hygiene practices should be followed when handling veterinary medicines.

Special Precautions for Storage

Store in a dry place below 30°C.
Do not refrigerate.
Keep out of reach of children.
Protect from light.

For veterinary use only. Consult a veterinarian before use.